The Japanese Ministry of Health and Welfare has implemented a policy of pay
ing physicians to explain the nature of the patient's medical condition and
rite treatment plan. We describe the precepts of this policy and examine e
thical dimensions of this development. We question whether this policy will
be sufficient to ensure patients will have the opportunity to become infor
med participants in medical decision making. The policy, also raises a broa
der philosophical question as to whether informed consent is a fundamental
ethical requirement of all doctor-patient encounters or an option that can
be exercised by physicians for financial gain. The impact of this policy in
Japan merits continued observation from abroad.